tiprankstipranks
AstraZeneca PLC (GB:AZN)
LSE:AZN
UK Market

AstraZeneca (AZN) Income Statement

Compare
589 Followers

AstraZeneca Income Statement

Last quarter (Q4 2024), AstraZeneca's total revenue was $14.89B, an increase of 23.84% from the same quarter last year. In Q4, AstraZeneca's net income was $1.50B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 54.07B$ 45.81B$ 44.35B$ 37.42B$ 26.62B
Gross Profit
$ 43.87B$ 37.77B$ 31.96B$ 24.98B$ 21.32B
Operating Expenses
$ 33.86B$ 29.58B$ 28.20B$ 23.92B$ 16.16B
Depreciation and Amortization
$ 6.69B$ 4.93B$ 5.25B$ 4.10B$ 2.90B
EBITDA
$ 17.12B$ 13.91B$ 9.09B$ 5.11B$ 8.08B
Operating Income
$ 10.00B$ 8.19B$ 3.76B$ 1.06B$ 5.16B
Other Income/Expenses
$ -1.31B$ -1.29B$ -1.26B$ -1.32B$ -1.25B
Pretax Income
$ 8.69B$ 6.90B$ 2.50B$ -265.00M$ 3.92B
Net Income
$ 7.04B$ 5.96B$ 3.29B$ 112.00M$ 3.20B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 4.53$ 3.81$ 2.12$ 0.08$ 2.44
Diluted EPS
$ 4.51$ 3.81$ 2.11$ 0.08$ 2.44
Weighted Average Shares Outstanding
1.55B 1.56B 1.55B 1.42B 1.31B
Weighted Average Shares Outstanding (Diluted)
1.56B 1.56B 1.56B 1.43B 1.31B
Currency in USD

AstraZeneca Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis